Black Race Worsens Transplant OutcomesRenal and Urology News13% and 14%, respectively), as was the rate of acute rejection (42% vs. 28%, and 31%, respectively). Allograft failure occurred in 27% of AA recipients compared with 16% among Hispanics and 17…
Proactive Investors USA & CanadaIsotechnika strikes licensing deal with Vifor Pharma, stocks riseProactive Investors USA & CanadaIsotechnika's chief executive, Robert Foster, said: “While the successful development of voclosporin for the preventi…
CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-3 AfternoonBeacon Equity ResearchTheir market cap is 13.06B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…
Alexion Pharmaceuticals (ALXN) Shares Given New $82.00 Price Target by Bank of …LocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in t…
CHKM, ALXN, HOLI, FSIN, EXAR, MOS are Stocks to Watch on Jan-2 AfternoonBeacon Equity ResearchTheir market cap is 13.24B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thre…
Mesa woman breathes new life after lung transplantEast Valley TribuneSo far, she hasn't shown any signs of transplant rejection, a good sign that the transplant has been successful. While she won't live a “normal” life, since she can get si…
Alexion Pharmaceuticals, Inc. (ALXN) – Analysts' Weekly Ratings ChangesLocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the ther…
CHKM, ALXN, HOLI, FSIN, EXAR, MOS are Stocks to Watch on Dec-30 AfternoonBeacon Equity ResearchTheir market cap is 13.30B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…
Trade Alert – Bristol-Myers Squibb at New HighsTradersHuddle.comThe Company offers products and experimental therapies to address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric dis…
CHKM, ALXN, HOLI, FSIN, EXAR, MOS are Stocks to Watch on Dec-30 MorningBeacon Equity ResearchTheir market cap is 13.25B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threa…